Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
3
×
biotech
boston blog main
clinical trials
crispr
editas medicine
3
×
life sciences
national blog main
abbvie
boston
boston top stories
cynthia collins
deals
gene editing
san francisco blog main
akouos
alnylam pharmaceuticals
alzheimer's disease
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
covid-19
deerfield management
detroit blog main
detroit top stories
drugs
durvalumab
europe blog main
europe top stories
fda
forty seven
fred hutch
What
ceo
editas
editing
experimental
gene
medicines
abbvie
acquisitions
allergan
alliance
announced
bio
biotech
blessing
bosley
check
clinical
collabs
covid
crispr
cusp
daniel
deal
depart
exits
genetic
gilead
gilead’s
help
humans
introduce
ipo
katrine
medicine
million
month
o’day
pact
partner
partnership
Language
unset
Current search:
allergan
×
" editas medicine "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial